2 active not recruiting. 2 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Active not recruiting 2 |
| Phase 3 | 2 | Active not recruiting 2 |
Follow Stargardt Disease: new trials by email Literature Review of Stargardt Disease trials Research Report on Stargardt Disease
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2/3 Study to Evaluate the Efficacy and Safety of Tinlarebant in Subjects With Stargardt Disease Tinlarebant, Placebo - STGD1, Stargardt Disease 1 | Phase 2 / Phase 3 | Active not recruiting | Belite Bio, Inc | 60 | 2024-07-31 | 2026-03-12 |
| A Phase 2/3 Trial to Assess the Efficacy and Safety of OCU410ST for Stargardt Disease OCU410ST - Stargardt Disease | Phase 2 / Phase 3 | Active not recruiting | Ocugen | 51 | 2023-08-25 | 2026-07-31 |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Eye Diseases (2) · Eye Diseases, Hereditary (2) · Genetic Diseases, Inborn (2) · Macular Degeneration (2) · Retinal Degeneration (2) · Retinal Diseases (2)
Belite Bio, Inc (1) · Ocugen (1)
United States (2) · Japan (1) · United Kingdom (1)
Jennifer Henrick, RN, MS (1) · Mohamed Genead, MD (1)